News About: Goverment
Tug of war between government and doctors looms
The Ministry of Health and Welfare plans to let the National Medical Center introduce the contentious prescription by generic name from next month.
However, the tug of war between the government and doctors is expe...
28 drug makers to face heavy penalty
Recently, the Ministry of Health and Welfare announced that the prices of locally-produced medicines by 28 pharmaceutical manufacturers will be reduced as these firms took improper profits by taking advantage of local...
FTA will hurt pharmaceutical sector
It's obvious that prices of the drugs will soar, which will damage domestic clients' access to drugs, if a U.S.-Korea free trade agreement goes through and the patent period of new drugs made by the United States is e...
Passage of bills likely to be delayed
The National Assembly will hold its regular session next month but passage of thorny issues such as a revision on the Pharmaceutical Affairs Law will be postponed ahead of the Presidential election in December.
Hea...
Experts to call for drug reclassification in promotion of OTC drugs.
Experts said that the non-prescription drug markets could be activated by reclassifying the prescription and non-prescription drugs instead of the current fixed rate system, which is implemented from this month.
Mr...
Lawmaker blames doctors' strike
Rep. Chang Bok-shim of the ruling Uri Party criticized doctors' threat of collective action against the government-proposed plan to let the National Medical Center implement the test-run prescription by generic name i...
KFDA to warn heart failure labelling to Avandia and Actos.
Health regulatory agency ordered a strong heart failure warning to the two thiozolidinedione diabetic drugs, Avandia and Actos.
The KFDA said on Aug. 17 that two thiazolidinedione antidiabetic drugs, Avandia (r...
Internal report shows doctors obstacle to prescription by generic name
The participatory government tried to implement the system of promoting the prescription by generic name in December 2003 but didn't fell short of making public in the face of strong opposition, according to an intern...
Drug makers urged to meet various versions of GMP
Under the government plan to strengthen competitiveness of domestic pharmaceutical industry by strengthening management of GMP Good Manufacturing Practice (GMP), local pharmaceutical manufacturers will be soon subject...
KFDA orders death warnings
On August 14, the government instructed drug makers to attach a stricter warning about the risk of death in patients when labeling recombinant human erythropoietin (epoetin alfa), produced using a mammalian cell line ...
